Personalized TCR-T: Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)

NCT05349890 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Malignant Epithelial Neoplasms

Interventions

BIOLOGICAL: TCR-transduced T cells
DRUG: CDX-1140
DRUG: Pembrolizumab

Sponsor

Providence Health & Services

Collaborators

[object Object]
[object Object]